Aveta Biomics, Inc. — Form D
Aveta Biomics, Inc. of BEDFORD, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-19. The offering totals $8.0M, of which $4.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2025-03-19
- Form: D
- Accession: 0001734691-25-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $4.5M
- Remaining: $3.5M
- Investors: 36
- Date of first sale: 2024-05-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-541386
Issuer
- Name: Aveta Biomics, Inc.
- CIK: 0001734691
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 110 GREAT ROAD, SUITE 302, BEDFORD, MA, 01730
- Phone: 339-927-5994
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Peter Dolan | Director | Bedford, MA |
| S. P. Kothari | Director | Bedford, MA |
| Parag Mehta | Director | Bedford, MA |
| David Page | Director | Bedford, MA |
| Bharat Tewarie | Director | Bedford, MA |
| Parag Mehta | Executive Officer | Bedford, MA |
| Guha Bala | Director | Bedford, MA |
| Sharmila Mudgal | Director | Bedford, MA |
| Sharmila Mudgal | Executive Officer | Bedford, MA |
| SP Kothari | Director | Bedford, MA |
Other filings by this issuer (2)
More